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The objective of this monograph on lead is to help you: 
□  Realize why lead continues to be a chemical hazard of great concern
□  Understand the known factors contributing to lead poisoning
□  Assess a patient's environmental or occupational exposure to lead
□  Effectively evaluate and manage lead-exposed patients
□  Utilize a variety of sources to locate further information on lead
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Lead toxicity
A hyperactive 5-year-old with disturbed hearing and hypochromic anemia
A 5-year-old boy is brought to your office by his mother, who is concerned that her child is hyperactive. At a parent- 
teacher conference last week, the kindergarten teacher said that he seems impulsive and has trouble concentrat­
ing, and recommended evaluation by a physician as well as by the school psychologist. The mother states that 
he has always seemed restless and easily distracted, but that these first 6 months in kindergarten have been 
especially trying.
Family history reveals that the boy lives with his sister, mother, and maternal grandparents in an older suburb of 
your community. The child’s monthly weekend visits to his father’s house are working out fine. However, he seems 
to be fighting more with his sister, who has an attention-deficit disorder and is repeating first grade. Since the 
mother moved in with her parents after her divorce 4 years ago, she has worked with the grandfather in an 
automobile radiator repair shop, where her children often come to play after school. She was just laid off, however, 
and expressed worry about increasing financial dependence on her parents. She also worries that the grand­
father, who has gout and complains increasingly of abdominal pain, may become even more irritable when he 
learns that she is pregnant. Her third child is due in 4 months.
On chart review, you see that the boy was last seen in your clinic for his preschool physical 1 year ago, results 
of which were normal. A note describes a very active 4-year-old who could dress himself without help but could 
not correctly name the primary colors. His vision was normal, but hearing acuity was below normal, and speech 
and language were slightly delayed. Immunizations are up to date.
Further history on that visit indicated adequate diet, with no previous pica. Spun hematocrit was diminished at 30%. 
Peripheral blood smear showed hypochromia and microcytosis. There was no evidence of blood loss, and stool 
examination was negative for occult blood. The diagnosis was “mild iron deficiency anemia,” and iron therapy 
was prescribed. The family failed to keep several follow-up appointments, but the child did apparently complete 
the prescribed 3-month course of iron supplements. He receives no medications at this time and has no known 
allergies.
On physical examination today, you note that the boy is in the tenth percentile for height and weight. His attention 
span is very short, making him appear restless, and he has difficulty following simple instructions. Except for lan­
guage and social skills, he has reached most important developmental milestones.
(a) What should be included in this boy's problem list?
(b) List several possible causes for the anemia.
(c) What tests would you order to confirm or rule out your diagnosis?
Answers are incorporated in Challenge answers (11) through (14) on pages 23-24.




□  Young children have a great 
potential for lead exposure 
and are especially suscep­
tible to its toxic effects.
□  Since blood lead readily 
crosses the placenta, 
lead poses a substantial 
threat to the developing 
fetus.
Q  Workers may bring lead 
dust home on skin and 
clothes and unknowingly 
expose family members.
By and large, children show a greater sensitivity to lead’s effects than 
adults do. The incomplete development of the blood-brain barrier in 
very young children (up to 36 months of age) increases the risk of 
lead's entry into the developing nervous system, which can result in 
prolonged neurobehavioral disorders. Children absorb and retain 
more lead in proportion to their weightthan do adults. Young children 
also show a greater prevalence of iron deficiency, a condition that 
can increase gastrointestinal absorption of lead.
Three to four million children in the United States (approximately 
17%) are at increased risk of lead poisoning. A breakdown according 
to socioeconomic and demographic strata shows that no economic 
or racial subgroup of children is free from the risk of having blood lead 
levels high enough to cause adverse health effects. Sizable num­
bers of children from families with incomes well above the poverty 
line have been reported to have elevated blood lead levels. The 
prevalence of elevated levels, nevertheless, remains highest among 
inner-city, underprivileged children who live in deteriorating pre- 
1970s housing containing leaded-paint surfaces.
Since lead readily crosses the placenta, the fetus is at great risk. 
Fetal exposure can cause potentially adverse neurologic effects 
in utero and during postnatal development. According to the Public 
Health Service, in 1984, more than 400,000 fetuses were exposed 
to lead through maternal blood lead concentrations associated with 
early developmental effects.
More than 1 million workers in over 100 different occupations may be 
exposed to lead. In lead-related industries, workers not only may 
inhale lead dust and lead oxide fumes, but may eat, drink, and smoke 
in or near contaminated areas, increasing the probability of lead 
ingestion. If showers and changes of clothing are not provided, 
workers can bring lead dust home on their skin, shoes, and clothing, 
thus inadvertently exposing family members.
Cfiatlenge
(1) Who else in the family or community discussed in the case study is at risk of lead poisoning?




Lead is a naturally occurring element that has been used almost 
since the beginning of civilization. Because of the many industrial 
activities that have brought about its wide distribution, lead is ubiqui­
tous in the environment today. All humans have lead in their bodies, 
primarily as a result of exposure to manmade sources.
Today, the major environmental sources of metallic lead and its salts 
are paint, auto exhaust, food, and water. For children, the most im­
portant pathways are ingestion of chips from lead-painted surfaces, 
inhalation of lead from automobile emissions, food from lead-sol- 
dered cans, drinking water from lead-soldered plumbing, and medi­
cations in the form of folk remedies.
The lead in automobile emissions may be inhaled directly or depos­
ited in the soil. Children playing near roads and freeways may not 
only breathe the exhaust fumes, but may come in contact with con­
taminated dirt. Automobile emissions may be an important source 
of lead for urban residents, particularly if traffic congestion is nearby.
The lead content of paint was not regulated until 1977. Many older 
structures, residential and commercial, have leaded paint that is 
peeling, flaking, and chipping. Children can ingest loose paint as a 
result of pica (compulsive eating of nonfood items) and through 
mouthing of items contaminated with lead from paint, dust, and soil. 
High levels of lead in soil and house dust have been associated with 
increased blood lead levels in children.
Food may contain lead from the environment or from containers. 
Agricultural vehicles are not required to use unleaded gasoline; 
consequently, lead can be deposited on and retained by crops, 
particularly leafy vegetables. Acidic foods have been found to leach 
lead from lead solder in cans and lead glazes used in making pottery 
and ceramicware. Water from leaded pipes, soldered plumbing, or 
water coolers is another potential source of lead exposure. Station­
ary or point sources of lead include mines and smelters.
Several folk remedies used in this country have been shown to 
contain large amounts of lead. Two Mexican folk remedies are 
azarcon and greta, which are used to treat "empacho," a colic-like 
illness. Azarcon and greta are also known as liga, Maria Luisa, 
aiarcon, coral, and rueda. Lead-containing remedies and cosmetics 
used by some Asian communities are chuifong tokuwan, pay-loo- 
ah, ghasard, baligoli, and kandu. Middle Eastern remedies include 
alkohi, kohl, surma, saoott, and cebagin.
□  The primary sources of 
environmental exposure to 
lead are leaded paint, auto 
emissions, and drinking 
water.
□  A wide variety of workers, 
hobbyists, and substance 
abusers may encounter po­
tentially high levels of lead. 
Certain folk remedies may 
also cause lead poisoning.
□  Lead enters the body pri­
marily through ingestion 
and inhalation.
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In addition to these environmental sources, many occupations, hob­
bies, and other activities result in potential exposures to high levels 
of lead and can put the entire family at risk of lead poisoning. 
Sources of lead exposure are listed below. Lead-glazed pottery, 
particularly if it is imported, is a potential source of exposure that is 
often overlooked. Even “safe” ceramicware can become harmful; 
dishwashing may chip or wear off the protective glaze and expose 
lead-containing pigments.
Inorganic lead enters the body primarily through inhalation and 
ingestion and does not undergo biologic transformation. In contrast, 
organic lead, found primarily in gasoline as tetraethyl lead, enters the 
body through inhalation and skin contact and is metabolized in the 
liver. In 1976 and in 1984, federal regulation drastically reduced the 
amount of lead in gasoline, and today organic lead in gasoline is not 
as great an environmental concern in the United States as it is in 
other countries, where it remains a serious hazard.
Sources of lead exposure
Occupational







Lead smelters and refiners 
Policemen
Steel welders or cutters 
Construction workers 
Rubber product manufacturers 
Gas station attendants 
Battery manufacturers 
Bridge reconstruction workers
Lead containing paint 






Environmental Hobbies and Related Activities
Glazed pottery making 
Target shooting at firing ranges 
Lead soldering (e.g., electronics) 
Painting
Preparing lead shot, fishing sinkers 
Stained-glass making 








(3) The case study suggests several sources of lead in the boy’s life. What are these sources ? What 
questions will you ask to gauge the extent of the boy’s exposure to each of these sources?





In the human body, inorganic lead is not metabolized but is directly 
absorbed, distributed, and excreted. The rate at which lead is 
absorbed depends on its chemical and physical form and on the 
physiologic characteristics of the exposed person (e.g., nutritional 
status and age). Inhaled lead deposited in the lower respiratory tract 
is completely absorbed. The amount of lead absorbed from the Gl 
tract of adults is typically 10% to 15% of the ingested quantity; for 
pregnant women and children, the amount absorbed can increase to 
as much as 50%. The quantity absorbed increases significantly 
under fasting conditions and with iron or calcium deficiency.
Once in the blood, lead is distributed primarily among three compart­
ments—blood, soft tissue (kidney, bone marrow, liver, and brain), 
and mineralizing tissue (bones and teeth). Mineralizing tissue 
contains about 95% of the total body burden of lead in adults.
Of the lead in the blood, 99% is associated with erythrocytes; the 
remaining 1% is in the plasma, where it is available for transport to 
the tissues. The blood lead not retained is either excreted by the 
kidneys or through biliary clearance into the gastrointestinal tract. In 
single-exposure studies with adults, lead has a half-life, in blood, of 
approximately 25 days; in soft tissue, about 40 days; and in the non- 
labile portion of bone, more than 25 years. Consequently, after a 
single exposure a person's blood lead level may begin to return to 
normal; the total body burden, however, may still be elevated.
The lead in mineralizing tissues accumulates in subcompartments 
that differ in the rate at which lead is resorbed. In bone there is both 
a labile component, which readily exchanges lead with the blood, 
and an inert pool. The lead in the inert pool poses a special risk 
because it is a potential endogenous source of lead. When the body 
is under physiologic stress such as pregnancy, lactation, or chronic 
disease, this normally inert lead can be mobilized and increase the 
lead level in blood. Because of these mobile lead stores, significant 
drops in a person's blood lead level can take several months or 
sometimes years, even after complete removal from the source of 
lead exposure.
For lead poisoning to develop, major acute exposures to lead need 
not occur. The body accumulates this metal over a lifetime and 
releases it slowly, so even small doses, over time, can cause lead 
poisoning. It is the total body burden of lead that is related to the risk 
of adverse effects.
□  Once in the bloodstream, 
lead is primarily distrib­
uted among three 
compartments— blood, 
soft tissue, and mineral­
izing tissue. The bones 
and teeth contain more 
than 95% of total lead
in the body.
□  In times of stress, the 
body can mobilize lead 
stores, thereby increasing 
the level of lead in the 
blood.
□  The body accumulates 
lead over a lifetime and 
normally releases it very 
slowly.
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Cfiaiieng
(5) What would likely be revealed by an X ray of the abdomen or long bones of a lead-exposed child?
(6) Why does the blood lead level fail to drop within a few days, even with complete removal from the 
source of exposure?
(7) Several weeks after chelation therapy and removal from the source of exposure, in some cases 
the patient's blood lead level is found to have increased again. What is the cause of this rebound 
phenomenon?
Physiologic Effects
□  Lead affects primarily the 
peripheral and central 
nervous systems, the 
blood cells, and metabolism 
of vitamin D and calcium. 
Lead also causes repro­
ductive toxicity.
Whether lead enters the body through inhalation or ingestion, the 
biologic effects are the same; there is interference with normal cell 
function and with a number of physiologic processes. The lowest 
observable blood lead levels associated with specific health effects 
in chronically exposed children and adults are shown in Figure 1.
Neurologic Effects
□  Neurologic deficits, as 
well as other effects 
caused by lead poisoning, 
may be irreversible.
The most sensitive target of lead poisoning is the nervous system. 
In children, neurologic deficits have been documented at exposure 
levels once thought to cause no harmful effects. In addition to the 
lack of a precise threshold, childhood lead toxicity may have perma­
nent effects. One study showed that damage to the central nervous 
system (CNS) that occurred as a result of lead exposure at age 2 
resulted in continued deficits in neurologic development, such as
6
Lead Toxicity
Figure 1. Effects of inorganic lead on children and adults' 
lowest observable adverse effect levels
□  Effects in children
generally occur at lower 
blood lead levels than in 
adults.
□  The developing nervous 
system in children can be 
affected adversely at 
blood lead levels of less 
than 10 ng/dl_.
lower IQ scores and cognitive deficits, at age 5. In another study that 
measured total body burden, primary school children with high tooth 
lead levels but with no known history of lead poisoning had larger 
deficits in psychometric intelligence scores, speech and language 
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with lower levels of lead. A recently published follow-up report of 
children with elevated lead levels in their teeth noted a sevenfold 
increase in failure to graduate from high school, lower class stand­
ing, greater absenteeism, more reading disabilities, and deficits in 
vocabulary, fine motor skills, reaction time, and hand-eye coordina­
tion 11 years later. The reported effects are more likely caused by 
the enduring toxicity of lead than by recent excessive exposures 
since the blood lead levels found in the young adults were low (less 
than 10 p.g/dL).
Hearing acuity, particularly at higher frequencies, has been found to 
decrease with increasing blood lead levels. Hearing loss may con­
tribute to the apparent learning disabilities or poor classroom behav­
ior exhibited by children with lead intoxication.
Adults also experience CNS effects at relatively low blood lead 
levels, manifested by subtle behavioral changes, fatigue, and im­
paired concentration. Peripheral nervous system damage, primarily 
motor, is seen mainly in adults. Peripheral neuropathy with mild 
slowing of nerve conduction velocity has been reported in asympto­
matic lead workers. Lead neuropathy is believed to be a motor 
neuron, anterior horn cell disease with peripheral dying-back of the 
axons. Frank wrist drop occurs only as a late sign of lead intoxica­
tion.
Hematologic Effects
Lead inhibits the body’s ability to make hemoglobin by interfering 
with several enzymatic steps in the heme pathway. Ferrochelatase, 
which catalyzes the insertion of iron into protoporphyrin IX, is quite 
sensitive to lead. A decrease in the activity of this enzyme results in 
an increase of the substrate, erythrocyte protoporphyrin (EP), in the 
red blood cells. Recent data indicate that the EP level, which has 
been used to screen for lead toxicity in the past, is not sufficiently 
sensitive at lower levels of blood lead and is therefore not as use­
ful a screening test for lead poisoning as previously thought. (See 
Laboratory Evaluation for further discussion of EP testing.)
Lead can induce two types of anemia. Acute high-level lead poison­
ing has been associated with hemolytic anemia. In chronic lead 
poisoning, lead induces anemia by both interfering with erythropoi- 
esis and by diminishing red blood cell survival. It should be empha­
sized, however, that anemia is not an early manifestation of lead 
poisoning and is evident only when the blood lead level is signifi­
cantly elevated for prolonged periods.
□  Lead inhibits several 
enzymes that are 
critical to the synthesis 
of heme.
□  Lead poisoning in 




A strong inverse correlation exists between blood lead levels and 
levels of vitamin D. Because the vitamin D-endocrine system is 
responsible in large part for the maintenance of extra- and intra­
cellular calcium homeostasis, it is likely that lead impairs cell growth 
and maturation and tooth and bone development.
Renal Effects
A direct effect on the kidney of long-term lead exposure is nephro­
pathy. Impairment of proximal tubular function manifests in ami­
noaciduria, glycosuria, and hyperphosphaturia (a Fanconi-like 
syndrome). There is also evidence of an association between lead 
exposure and hypertension, an effect that may be mediated through 
renal mechanisms. Gout may develop as a result of lead-induced 
hyperuricemia, with selective decreases in the fractional excretion 
of uric acid before a decline in creatinine clearance. Renal failure 
accounts for 10% of deaths in patients with gout.
Reproductive and Developmental Effects
An increased frequency of miscarriages and stillbirths among women 
working in the lead trades was reported as early as the turn of the 
century. Although the data concerning exposure levels are incom­
plete, these effects were probably a result of far greater exposures 
than are currently found in lead industries. Reliable dose-effect data 
for reproductive effects in women are still lacking today.
Increasing evidence indicates that lead not only affects the viability 
of the fetus, but development as well. Developmental conse­
quences of prenatal exposure to low-levels of lead include reduced 
birth weight and premature birth. Lead is an animal teratogen, and 
the results of at least one study suggest a dose-dependent relation 
to the rate of minor malformations in humans.
The effects of lead on the male reproductive system in humans have 
not been well characterized. The available data support a tentative 
conclusion that testicular effects, including reduced sperm counts 
and motility, may result from chronic exposure to lead.
Carcinogenic Effects
Case reports have implicated lead as a potential renal carcinogen 
in humans, but the association remains uncertain. Soluble salts, 
such as lead acetate and lead phosphate, have been reported to 
cause kidney tumors in rats.
□  Lead interferes with a 
hormonal form of 
vitamin D, which affects 
multiple processes in the 
body, including cell 
maturation and skeletal 
growth.
□  Lead-induced chronic 
renal insufficiency may 
result in gout.
□  Maternal lead stores
readily cross the placenta, 
placing the fetus at great 
risk.
□  EPA's Science 
Advisory Board has 
recommended that lead 






(8) What are the major effects of lead on the human body?
(9) How do lead’s effects differ in children and adults?
Clinical Evaluation
History and Physical Examination
The first signs of lead 
poisoning in children are 
often subtle neurobehav- 
ioral problems that 
adversely affect class­
room behavior and social 
interaction.
Speech or hearing 
impairments, or both, 
are not uncommon in 
lead-exposed children.
Medical evaluation of a patient with suspected lead exposure in­
cludes a full workup and medical history. Clues to potential exposure 
are often obtained by discussing the following with the family:
occupational history of all home occupants
family history, including use of unusual medicines
location, age, and physical condition of residence, 
school, day-care center, etc.
home remodeling activities
condition of household pets
hobbies of all family members
use of imported or glazed ceramics
drinking water source and type of pipe
nutritional status
proximity to industrial facilities and hazardous waste sites
10
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The physical examination should include special attention to the 
hematologic, cardiovascular, gastrointestinal, and renal systems. 
The nervous system, including behavioral changes, should be 
carefully evaluated. A purplish line on the gums (lead line) is rarely 
seen today, but if present, usually indicates severe and prolonged 
lead poisoning.
For children, hearing, speech, and other developmental milestones 
should be carefully evaluated and documented. In certain geo­
graphic areas, iron deficiency is common in children 9 to 24 months 
of age. Since iron and calcium deficiencies are known to enhance 
the absorption of lead and to aggravate pica, it is especially 
important to assess the nutritional status of young children.
Signs and Symptoms
Because of differences in individual susceptibility, symptoms of lead 
intoxication and their onset may vary. With increasing exposure, 
the severity of symptoms can be expected to increase. Those symp­
toms most often associated with varying degrees of lead toxicity are 
listed below. In the early stages of symptomatic lead intoxication or 
mild toxicity, blood lead levels generally range from 35 to 50 p.g/dL 
(micrograms of lead per 100 milliliters of blood) in children and 40 
to 60 p.g/dL in adults. Severe toxicity is frequently found in associa­
tion with blood lead levels of 70 |ig/dLor more in children and 
100 (ig/dL or more in adults.






















Paresis or paralysis 
Encephalopathy-may 
abruptly lead to seizures, 
changes in conscious­
ness, coma, and death 
Lead line (blue-black) on 
gingival tissue 
Colic (intermittent, severe 
abdominal cramps)
□  Some persons with 




Some of the hematologic signs of lead poisoning mimic other dis­
eases orconditions. In the differential diagnosis of microcytic anemia, 
lead poisoning can usually be ruled out by obtaining a venous blood 
lead concentration; if the blood lead level is less than 25 j^g/dL, the 
anemia usually reflects iron deficiency or hemoglobinopathy. Two 
rare diseases, acute intermittent porphyria and coproporphyria, also 
result in heme abnormalities similar to those of lead poisoning.
Other effects of lead poisoning can be misleading. Patients exhib­
iting neurologic signs due to lead poisoning have been treated only 
for peripheral neuropathy or carpal tunnel syndrome, delaying 
treatment for lead intoxication. Failure to correctly diagnose lead- 
induced gastrointestinal distress has led to inappropriate abdominal 
surgery.
Laboratory Evaluation
If pica or accidental ingestion of lead-containing objects (curtain 
weights, fishing sinkers, etc.) is suspected, an abdominal radiograph 
should be taken. Hair analysis is not usually an appropriate assay for 
lead toxicity since no correlation has been found between the 
amount of lead in the hair and the exposure level. The probability of 
environmental lead contamination of a laboratory specimen and 
inconsistent sample preparation make the results of hair analysis 
difficult to interpret. Suggested laboratory tests to evaluate lead in­
toxication include the following:
CBC with peripheral smear 
Blood lead level
Erythrocyte protoporphyrin level 
BUN and creatinine 
Urinalysis
□  Basophilic stippling is 
not always seen in lead- 
poisoned patients.
CBC with Peripheral Smear. In a lead-poisoned patient, the hema­
tocrit and hemoglobin values may be slightly to moderately low. The 
differential and total white count may appear normal. The peripheral 
smear may be either normochromic and normocytic or hypochromic 
and microcytic. Basophilic stippling is usually seen only in patients 
who have been significantly poisoned for a prolonged period. Eo- 
sinophilia may appear in lead-intoxicated patients but does not show 
a clear dose-response effect.
Lead Toxicity
Blood Lead Level. A blood lead (Pb-B) level Is the most useful 
screening and diagnostic test for lead exposure. A Pb-B level 
reflects lead's dynamic equilibrium between absorption, excretion, 
and deposition in soft- and hard-tissue compartment. As such, 
Pb-B levels underrepresent the total body burden; nevertheless, it 
is the most widely accepted and commonly used measure of lead 
exposure. Pb-B levels respond relatively rapidly to abrupt or inter­
mittent changes in lead intake (for example, ingestion of lead paint 
chips by children)and, within a limited range, bear a linear relation­
ship to those intake levels.
Lead is most harmful to children under 7 years of age. Every child 
who has a developmental delay, behavioral disorder, or speech im­
pairment, or who may have been lead-exposed, should be consid­
ered for a Pb-B test. Equally important, siblings, housemates, and 
playmates of children with suspected lead toxicity probably have 
similar exposures to lead and should be promptly screened. For oc­
cupationally exposed adults, consult the federal lead standard for 
the mandated type and frequency of lead screening (p. 19, Work­
place, Air).
Today, the average blood lead level in the United States population 
is about 10 (ig/dL, down from an average of 16 |ig/dL, the level 
before the legislated removal of lead from gasoline. This present 
background level is about 3 times higher than the average level 
found in some remote populations and 15 to 30 times the theoreti­
cal value calculated for preindustrial humans.
The levels defining lead poisoning have been progressively declin­
ing. (See Biologic Guidelines in Standards and Regulations.) Cur­
rently, the consensus level of concern for children is 10 to 15 )ig/dL. 
Effects on stature have been reported to begin at levels as low as 
4 ng/dL, the present limit for accurate Pb-B measurement. Taken 
together, effects occur over a wide range of Pb-B concentrations, 
with no indication of a threshold. No safe level has yet been found 
for children. Even in adults, effects are being discovered at lower 
and lower doses as more sensitive analyses and measures are de­
veloped.
EP andZPP Levels. Until recently, the test of choice for screening 
asymptomatic children and other populations at risk was erythrocyte 
protoporphyrin (EP), commonly assayed as zinc protoporphyrin 
(ZPP). An elevated level of protoporphyrin in the blood is a result of 
accumulation secondary to enzyme dysfunction in the erythrocytes 
and reaches a steady state in the blood only after the entire 
population of circulating erythrocytes has turned over, about 120 
days. Consequently, it lags behind Pb-B levels and is an indirect 
measure of long-term lead exposure.
□  The best screening and 
diagnostic test for lead 
poisoning is a blood 
lead level.
□  Using an EP or ZPP assay 
to "screen" children for 
lead poisoning is not as 
useful as once thought.
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The major disadvantage of using EP (ZPP) testing as a method for 
lead screening is that it is not sensitive at the lower levels of lead poi­
soning. Data from the second National Health and Nutrition Exami­
nation Survey (NHANESII) indicate that 58% of 118 children with Pb- 
B levels above 30 |ig/dL had EP levels within normal limits. This 
finding shows that a significant number of children with lead toxicity 
would be missed by reliance on EP (ZPP) testing alone as the 
screening tool. An EP (ZPP) level is still useful, however, in better 
identifying those patients whose Pb-B levels are on the rise and in 
screening patients for iron deficiency anemia.
Normal values of ZPP are usually below 35 n-g/dL. Hyperbilirubine­
mia (jaundice) will cause falsely elevated readings when the hema- 
tofluorometer is used. EP is elevated in iron deficiency anemia and 
in sickle cell and other hemolytic anemias. In erythropoietic proto­
porphyria, an extremely rare disease, EP is markedly elevated 
(usually above 300 |ig/dL).
□  Renal function may be BUN, Creatinine, and Urinalysis. These parameters may reveal only
impaired in lead-exposed |atei significant effects of lead on renal function. Renal function in
persons. adults can also be assessed by measuring the fractional excretion of
uric acid (normal range 5% to 10%; less than 5% in saturnine gout; 
greater than 10% in Fanconi syndrome).
CfiaCCenge-^r
(10) What should be included in the problem list for the patient described in the case study?
(11) List several possible causes of the boy's anemia.
(12) You have just learned from the laboratory that the boy has a ZPP level of 350 ¡ig/dL. What are the 
possible causes of this elevated value?




It is not sufficient to provide treatment only; the patient and lead 
source must be permanently separated. After diagnosing lead 
poisoning, the physician should call upon the resources of the local 
health authority to determine the lead source (home, workplace, 
etc.). If the lead poisoning is caused by leaded paint in the home, the 
patient and all other family members should be rehoused until the 
home has undergone safe and satisfactory lead abatement. Family 
members and other persons likely to have been exposed should be 
tested for lead poisoning. Steps should be taken to identify and 
correct dietary deficiencies, particularly of calcium and iron, and to 
educate family members on the preventable hazards of lead.
The most reliable index of exposure is a measurement of Pb-B 
concentration; this and the EP (ZPP) results should be used as 
criteria for therapeutic decisions. In those asymptomatic children 
having Pb-B levels below 25 ng/dl_, treatment is probably not indi­
cated, and removal from the source will be action enough. Patient 
follow-up to confirm a decreasing Pb-B level is needed, however.
Chelation has potentially serious side effects. In rare cases, the 
chelating agent calcium disodium ethylenediaminetetraacetic acid 
(CaEDTA) has caused proteinuria, microscopic hematuria, proximal 
tubule damage, hypercalcemia, and fever. Before instituting this 
therapy or using the chelation challenge test, the patient should be 
hospitalized and a physician experienced in chelation should be 
consulted. Such physicians can be identified by contacting an 
accredited regional poison control center, university medical center, 
or state or local health department.
The decision to proceed with chelation therapy for children with 
Pb-B levels between 25 and 55 |ig/dL will usually depend on the 
results of the provocative EDTA test. This mobilization challenge is 
based on urinary clearance of lead after a single dose of CaEDTA. 
The Centers for Disease Control (CDC) recommends that longer- 
term chelation therapy be started if the total amount of lead excreted 
in urine in 8 hours exceeds 200 (ig or if the ratio of lead excreted (in 
p.g) to CaEDTA administered (in mg) is 0.7 or more. CDC also recom­
mends that children who have Pb-B levels greater than 55 |ig/dL be 
chelated immediately without this provocative EDTA test. In most 
cases, chelation therapy should not continue for more than 5 days at 
a time.
□  All therapeutic chelating 
agents have potentially 
adverse side effects and 
should be used cautiously.
□  The type of therapy required 
will normally depend on the 
patient's Pb-B level. 
Asymptomatic patients 
with Pb-B levels below
25 ng/dL usually require only 
separation from the source 
of exposure; those with 
levels above 55 ng/dL may 
require chelation therapy.
□  The EDTA challenge test 
will indicate the extent of 
lead stores in the body.
It may aid in the decision 
to institute chelation 
therapy for a patient with 
a Pb-B level between 25 
and 55 ng/dL.
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CaEDTA and BAL (British anti-Lewisite, dimercaprol), either singly 
or in combination, are the most commonly used chelating agents in 
the United States. When lead encephalopathy is present, BAL is 
usually administered in combination with CaEDTA. Two new and 
promising chelating agents now under investigation are dimercap- 
tosuccinic acid (DMSA) and 2,3-dimercapto-propane-1-sulphonate 
(DMPS). Both are water-soluble derivatives of BAL; both have been 
used successfully in the treatment of other heavy metal poisonings.
D-penicillamine is the only commercially available oral chelating 
agent, but its use in lead poisoning is still considered experimental. 
It is not as effective as other chelating agents and its specific mecha­
nism of action is not well understood. Toxic side effects occur in as 
many as 20% of patients given D-penicillamine, although serious 
adverse effects noted during long-term administration for other 
indications are unlikely to occur during short-term metal chelation.
Note: For background to the protocols, precautions, and limitations 
of the EDTA challenge test, and of chelation therapy in general, 
consults. Piomellietal., Journal of Pediatrics, 1984; 105:523-32.
(14) The laboratory results indicate that the Pb-B level of the child in the case study is 50 \xg/dL. 
What treatment will you recommend for the boy and to his family?
(15) Who could you contact for medical consultation regarding this boy’s case?




The number of federal standards and regulations reflect the extent 
to which lead is considered a public health problem. In some cases, 
the lead levels are mandated; in others, they are only recommended 
standards (Table 1).
Table 1. Summary of standards and regulations for lead
Agency* Focus Level Comments
CDC Blood 25 jig/dL Advisory; level of concern 
(likely to be lowered)
OSHA Air 50 jag Pb/m3 Regulation; PEL1’ over 8-hour 
workday
OSHA Blood 60 (ag/dL Regulation; medical removal 
from exposure
ACGIH Air 150 jig  Pb/m3 Advisory; TWA®
EPA Air 1.5 jag Pb/m3 Regulation; 3-month average
EPA Water 50 jag Pb/L Regulation; may be lowered to 
5 jig  Pb/L
FDA Food 100 jig  Pb/day Advisory
CPSC Paint 600 ppm (0.06%) Regulation; by dry weight
*ACGIH = American Conference of Governmental Industrial Hygienists; CDC = 
Centers for Disease Control; CPSC = Consumer Products Safety Commission; 
EPA = Environmental Protection Agency; FDA = Food and Drug Administration; 
OSHA = Occupational Safety and Health Administration
tP E L  (Permissible Exposure Limit) = highest level of lead in air, averaged over 
an 8-hour workday, to which a worker may be exposed.
§TWA (Time-Weighted Average) = air concentration for a normal 8-hour workday 




□  CDC is considering lowering 
the recommended action 
level for lead poisoning 
in children.
□  Several states require 
primary care physicians 
to report cases of lead 
poisoning.
Biologic Guidelines
Lead levels that in the past were considered safe are now considered 
hazardous. As new information has emerged about the neurologic, 
reproductive, and possible hypertensive toxicity of lead, and as more 
sensitive parameters are developed, the levels defining lead poison­
ing have been progressively lowered. Between 1986 and 1988, sev­
eral studies demonstrated neurobehavioral impairment in lead-ex­
posed children with blood lead levels as low as 10 to 15 (ig/dL. As 
more data become available, the definition of lead toxicity level will 
likely continue to be lowered (Figure 2).
Figure 2. CDC's action level for blood lead in children has 
steadily declined.
1960- 1970- 1985- 1990s
1970 1985 present
Physician Reporting Requirements. Several states require primary 
care physicians and persons in charge of screening programs to 
report both presumptive and confirmed cases of lead toxicity (usu­
ally, a Pb-B level of greater than 25 |ag/dL and a ZPP level of greater 
than 35 (ig/dL) to the appropriate health agency so that abatement 
of the lead source, education of the patient, and remediation steps 
can be undertaken. In many states, laboratories performing Pb-B or 





The federal lead standard specifies the permissible exposure limit 
(PEL) of lead in the workplace, the frequency and extent of medical 
monitoring, and other responsibilities of the employer. The Occupa­
tional Safety and Health Administration (OSHA) has set a PEL of 
lead in workroom air at 50 )j,g/m3 averaged over an 8-hour workday. 
For those exposed to air concentrations at or above the action level 
of 30 (ig/m3 for more than 30 days per year, OSHA mandates periodic 
determination of Pb-B levels. If a Pb-B level is found to be greater 
than 40 ng/dL, the worker must be notified in writing and provided 
medical examination. If a worker's Pb-B level reaches 60 jag/dL, the 
employer is obligated to remove the employee from excessive 
exposure, with maintenance of seniority and pay, until the em­
ployee's Pb-B level falls below 40 jag/dL. A copy of the lead standard 
can be obtained by calling your regional office of OSHA.
Environment
Air
Occupational exposure limits are generally set to accommodate 
8-hour workdays and healthy persons; they bear little relation to en­
vironmental limits, which are set to protect the most susceptible 
persons in the general population. EPA requires that the concentra­
tion of lead in air the general public may breathe shall not exceed 
1.5 |ig/m3 averaged over a calendar quarter. This standard will 
probably be lowered. To reduce the amount of lead released into the 
environment, in 1987, EPA instituted a phase-down limiting the level 
of lead in leaded gasoline to 0.1 grams per gallon and the level in 
unleaded gasoline to 0.05 grams per gallon.
Drinking Water
EPA is required to set drinking water standards with two levels of 
protection. The primary standards define contaminant levels in 
drinking water as levels above which the water source requires 
treatment. These maximum contaminant levels (MCL) are limits en­
forceable by law and are set as close as possible to the maximum 
contaminant level goals (MCLG), the levels determined to be safe by 
toxicologic and biomedical considerations, independent of feasibil­
ity. EPA's proposed goal for lead in drinking water is zero. The 
current MCL for lead is 50 (j.g/L; a lower level of 5 |ig/L has been 
proposed. EPA estimates that about 20% of the U.S. population 
(including 3.8 million children) consumes drinking water with lead 
levels above 20 |ig/L.
□  OSHA has set required 
standards for the amount 
of lead allowed in workroom 
air at 50 |ig/m3 averaged over 
an 8-hour workday.
□  EPA will probably lower 
its present ambient air 
standard for lead.
□  EPA's proposed goal for lead 
in drinking water after treat­
ment is zero.
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The use of lead solder and other lead-containing materials in con­
necting household plumbing to public water supplies was banned by 
EPAasof June 1988. Many older structures, however, still have lead 
pipe or lead-soldered plumbing internally, which may substantially 
increase the lead content of water at the tap. Regulations controlling 
the lead content of drinking-water coolers in schools went into effect 
in 1989.
Food
Most lead in food comes 
from solder in cans or 
glazes on ceramicware.
Regulating lead contamination in foods is the responsibility of the 
Food and Drug Administration (FDA). FDA has set agoal of less than 
100 ng/day as the total lead intake by children 1 to 5 years of age. 
Lead in food and beverages is encountered by virtually this entire 
age group in the United States. About 5% of these children ingest 
enough lead from food and beverages to be at risk for adverse health 
effects.
FDA has estimated that about 20% of all dietary lead comes from 
canned food and that about two-thirds of that results from lead solder 
in cans. The number of food cans that are lead-soldered continues 
to decline. In 1979, over 90% of all food cans were lead soldered; 
in 1986, this figure was 20%, or less than about 2 million cans. It is 
important to note that imported canned foods are not included in 
these figures and may still contain lead. Imported glazed ceramics 
and lead-containing pottery are also potential sources of danger­
ously high levels of lead.
Paint
Today, paint intended for 
residential use is limited 
to 0.06% lead content.
Since 1977, the Consumer Product Safety Commission has limited the 
lead in most paints to 0.06% (600 ppm by dry weight). Paint for 
bridges and marine use may contain greater amounts of lead.
Chaileng*
(17) Regarding the facts reported in the case study, should public health authorities or regulatory agencies 
be notified? Why?
(18) You learn from the boy’s mother that her place of employment had poor ventilation and no provision 
for respiratory protection, shower facilities, or work clothes. She ate lunch and smoked in the repair 
shop. “In fact, ’’ she says, “I wonder if my layoff has anything to do with the blood test the company 
had me get.” The company’s test indicated that her Pb-B level was 62 [ig/dL. What advice could you 





Cullen MR, Robins JM, Eskenazi B. Adult inorganic lead intoxication: presentation of 31 new cases and a review 
of recent advances in the literature. Medicine (Baltimore)l 983:62:221-47.
Gerber GB, Leonard IA, Jacquet P. Toxicity, mutagenicity and teratogenicity of lead. Mutat Res 1980;76:115-41.
Kehoe RA. Occupational lead poisoning: clinical types. J Occup Med 1972;14:298-300.
Piomelli S, Needleman HL, Rosen JF. Lead poisoning. American Academy of Pediatrics Update (audiotape 
available) 1988; 9 (No. 4):1-9.
Putnam RD. Review of toxicology of inorganic lead. Am Ind Hyg Assoc J 1986;47:700-03.
Neurobehavioral Development
Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. Longitudinal analyses of prenatal and post­
natal lead exposure and early cognitive development. N Engl J Med 1987;316:1037-43.
Needleman HL, Gunnor C, Leviton A, et al. Deficits in psychologic and classroom performance of children with 
elevated dentine lead levels. N Engl J Med 1979;300:689-95.
Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to lead in childhood. 
An 11-year follow-up report. N Engl J Med 1990;322:83-8.
Schwartz J, Otto D. Blood lead, hearing thresholds, and neurobehavioral development in children and youth. Arch 
Environ Health 1987;42:153-59.
Hematologic Effects
Moore MR, Goldberg A, Yeung-Laiwah AC. Lead effects on the heme biosynthetic pathway. Ann N Y Acad Sci 
1985;191-202.
Nephropathy
LurakisMF, PitoneJM. Occupational lead exposure, acute intoxication, and chronic nephropathy: report of a case 
and review of the literature. J Am Osteopath Assoc 1984;83:361-66.
Reproductive Effects
Mitchell JW, ed. Occupational medicine forum: lead toxicity and reproduction. J Occup Med 1987;29:397-9.
Uzych L. Teratogenesis and mutagenesis associated with the exposure of human males to lead: a review. Yale 
J Biol Med 1985;58:9-17.
Sources of lead exposure
Kunkel DB. The toxic emergency. Emergency Medicine 1986;18(Mar):207-17.
Drinking Water




Agency for Toxic Substances and Disease Registry. The nature and extent of lead poisoning in children in the 
United States: A report to Congress. Atlanta: US Department of Health and Human Services, Public Health 
Service, 1988. DHHS report no. 99-2966.
Agency for Toxic Substances and Disease Registry. Toxicological profile for lead. Atlanta: US Department of 
Health and Human Services, Public Health Service, 1988.
Centers for Disease Control. Preventing lead poisoning in young children: a statement by the Centers for Disease 
Control, January 1985. Atlanta: US Department of Health and Human Services, Public Health Service, 1985. 
DHHS report no. 99-2230.
Centers for Disease Control. Criteria for a recommended standard: occupational exposure to inorganic lead 
revised criteria. Atlanta: US Department of Health, Education, and Welfare, Public Health Service, 1978. 
Report no. (NIOSH) 78-158.
Centers for Disease Control. Lead poisoning following ingestion of homemade beverage stored in a ceramic 
jug-New York. Atlanta: US Department of Health and Human Services. MMWR 1989;38(21):379-80.
Centers for Disease Control. Occupational and environmental lead poisoning associated with battery repair 
shops-Jamaica. Atlanta: US Department of Health and Human Services. MMWR 1989;38(27):474-81.
Centers for Disease Control. Cadmium and lead exposure associated with pharmaceuticals imported from 
Asia-Texas. Atlanta: US Department of Health and Human Services. MMWR 1989;38(35):612-4.
Centers for Disease Control. Surveillance for occupational lead exposure-United States, 1987. Atlanta: US 
Department of Health and Human Services. MMWR 1989;38(37):642-6.
Centers for Disease Control. Lead poisoning in bridge demolition workers-Massachusetts. Atlanta: US Depart­
ment of Health and Human Services. MMWR 1989;38(40):687-94.
Environmental Protection Agency. Air quality criteria for lead, Vol 2. Research Triangle Park, North Carolina: 
US Environmental Protection Agency, Office of Health and Environmental Assessment. Report no. EPA-600/ 
8-83/028bF.
Answers to Pretest and Challenge Questions
Pretest questions are found on page 1. Challenge questions begin on page 3.
(1) All members of the family are at risk; they should be promptly evaluated and, if necessary, treated. The 
mother’s unborn child is also at risk. Workers in the radiator repair shop and their families, and any of the 
children’s playmates who have accompanied them to the repair shop after school, should also be screened.
(2) The boy’s mother is 5 months pregnant. Since the placenta presents no barrier to lead, the fetus’ blood lead 
level is likely to be similar to that of the mother. It is during the initial weeks of pregnancy that the neurologic 
system of the conceptus is formed; therefore, damage to the fetus may have already occurred. The mother 
is no longer working at the repair shop, but you should alert her and the family to the possibility of continued 
lead exposure via the grandfather, who may be bringing lead dust home on his skin, shoes, or clothes.
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Lead Toxicity
(3) Two of the obvious sources of lead suggested in the case study are leaded paint at home (paint flakes, 
household dust, and soil) and fumes and dust from solder at the radiator repair shop. You should determine 
if the boy ever had pica (a compulsive eating of nonfood items, to be distinguished from normal hand-to-mouth 
behavior of children). Pica is more common in children aged 2 to 5, so it is unlikely that this is a present 
behavior. Exposure to high levels of lead at the radiator repair shop is very possible, and you need to ascertain 
the type and length of the boy’s play at the shop.
(4) To evaluate less obvious, but possible, sources of lead exposure, you might inquire about the proximity of 
the child’s home and play areas to freeways, hazardous waste sites, and industry. The occupations of all 
adults in the household are important; children of lead-exposed workers have been shown to have higher lead 
levels than control groups. Do any of the boy’s associates or does the father have hobbies involving lead, 
such as those mentioned on page 4? You might also inquire whether the home is undergoing remodeling, 
whether any home or folk remedies are used, if glazed ceramicware is used for food, or if there are lead or 
lead-soldered pipes in the house that could contaminate the drinking water.
(5) If a child does not have pica and there is nothing to suggest that a lead-containing object has recently been 
ingested, an abdominal X ray will likely be negative. On long-bone radiograms, opacities in the metaphysial 
plates may be seen after 4-8 weeks or more of lead exposure. These "lead lines" (which are due to dense 
zones of calcium and not deposited lead) are more likely to be found in larger bones (i.e., radius and tibia) 
than in smaller bones (i.e., ulna and fibula). When "lead lines" are seen in the smaller bones, it may be 
indicative of a longer exposure, usually several months. Radiographs are helpful only in the rare circum­
stances that they are positive. Negative X rays do not rule out lead poisoning.
(6) Even with complete removal from the source of exposure, the blood lead level will drop only gradually 
because, without chelation, lead is only slowly excreted. In addition, even as it is excreted, it may be replaced 
by lead currently stored in bones and teeth.
(7) This rebound phenomenon is due to the mobilization of lead from the body’s stores in bones and teeth.
(8) The major effects of lead on the human body are damage to the neurologic, hematologic, renal, and 
reproductive systems.
(9) Because of an incompletely developed blood-brain barrier, children under 36 months of age are particularly 
susceptible to neurologic damage at very low blood lead levels. Since children (to age 7) are more sensitive 
to lead’s effects, most adverse effects of lead are often manifested at lower blood lead levels in children than 
in adults.
(10) History suggests delayed language ability, slightly impaired hearing, short stature, possible attention deficit 
disorder, and anemia. The child is also experiencing passive exposure to maternal cigarette smoke and 
family disruption (secondary to divorce).
(11) Three of the most common causes of microcytic anemia are iron deficiency, hemoglobinopathy, and lead 
poisoning. In lead-poisoned patients, anemia is usually evident only when the Pb-B level is significantly 
elevated for prolonged periods. It manifests in only a relatively small number of children with chronic lead 
poisoning. It is possible for a patient to be both lead-poisoned and to have anemia due to some other cause. 
The relative rarity of nutritional iron deficiency in this boy's age group and the absence of evidence for blood 
loss suggest consideration of other etiologies to explain the anemia.
(12) An elevated ZPP level is most often due to iron deficiency anemia, hemolytic anemias, or lead poisoning. A 
rare disease that may cause the ZPP level to be markedly elevated is erythropoietic protoporphyria.
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(13) To confirm lead poisoning, the besttest is a venous Pb-B level; a Pb-B level greaterthan 25 (ig/dL is diagnostic 
of lead poisoning. If the Pb-B level is below 25 p.g/dL, then a serum ferritin level and other iron studies can 
be used to determine if iron deficiency anemia exists.
(14) With an elevated Pb-B level of 50 jag/dL and a ZPP level of 350 p.g/dL, the conclusion is that the boy is lead- 
poisoned. It is important to immediately identify and eliminate all sources of lead exposure for both the boy 
and his family. The decision whether to use chelation, and when, should be made in consultation with a 
physician experienced in chelation. Adequate diet for the family should be stressed.
(15) You should consult with a physician experienced in treating lead-poisoned patients. To identify such physi­
cians, contact your state or local health department, a university medical center, or a certified regional poison 
control center.
(16) Knowing the subgroups at greatest risk of lead exposure, you should take every opportunity to educate these 
subpopulations, your colleagues, and the community about the hazards of lead poisoning and the steps to 
prevent its occurrence. Those children and members of the community whom you suspect may be in danger 
of lead poisoning should be promptly screened.
(17) In certain states, public health authorities must be notified if a patient’s Pb-B level and ZPP level exceed 
certain limits. This boy would likely fall into that category. In any case, you should contact your state or local 
health department so all sources of lead in the home can be identified and abated. You should also notify 
OSHA so the radiator repair shop can be brought, if required, into compliance with the federal lead standard. 
A NIOSH health hazard evaluation could also be requested. The reason for notifying these agencies is to 
prevent lead exposure in others.
(18) The federal lead standard mandates that a worker with a Pb-B level of 60 jig/dL or higher undergo medical 
removal from the lead hazard and be reassigned with retention of job seniority and pay. In addition to referring 
her for obstetrical evaluation, you should recommend that the mother talk to her employer, employee repre­
sentative, and OSHA to clarify her work status under the lead standard and possible reinstatement 
procedures.
Sources of Information
More information on the adverse effects of lead and the treatment and management of lead-exposed persons can 
be obtained from ATSDR, your state and local health departments, and university medical centers. Case Studies 
in Environmental Medicine: Lead Toxicity is one of a series. For other publications in this series, please use the 
order form on the back cover. For clinical inquiries, contact ATSDR, Division of Health Education, Office of the 




Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding CME credits and CEUs is a posttest score of 70% or better.
The Centers for Disease Control (CDC) is accredited by the Accreditation Council for Continuing Medical 
Education (ACCME) to sponsor continuing medical education for physicians, and by the Council on the Continuing 
Education Unit (CCEU) to sponsor continuing education units for other health professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 credit hour 
of continuing medical education (CME) credit in category 1 of the Physician's Recognition Award of the American 
Medical Association and 0.1 hour of continuing education units (CEU) for other health professionals upon 
completion of this monograph.
This program has been reviewed and is acceptable for 1 prescribed hour by the American Academy of Family 
Physicians (term of approval: through March 16,1991). For specific information, please consult the AAFP Office 
of Continuing Medical Education.
The American College of Emergency Physicians (ACEP) has approved this program for 1 hour of ACEP Category 
1 credit.
The American Osteopathic Association (AOA) has approved this program for 1 credit hour of Category 2-B AOA- 
CME credit.
To receive continuing education credit (CME or CEUs), complete the Posttest on page 26 in the manner shown 
in the sample question below. Circle all correct answers.







After you have finished the Posttest, please transfer your answers to the answer sheet on the inside back cover 
and complete the evaluation on the lower half of that page. Fold, staple, and mail the back cover to Continuing 
Education Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health Education, E33, 
1600 Clifton Road, Atlanta, GA 30333. Your confidential test score will be returned with an indication of where 
the correct answers can be found in the text. Validation of earned CME credit and CEUs will also be forwarded 
to participants, and their names, if requested, will be placed on the mailing list to receive other issues in the Case 




Circle all correct answers and transfer your answers to page 27.
1. Early indications of lead poisoning in children may be:
a. inappropriate classroom behavior
b. anemia
c. impaired speech or hearing
d. fatigue and lethargy
e. dermal rash
2. A laboratory evaluation for lead toxicity might include:
a. CBC with peripheral smear
b. blood lead level
c. zinc protoporphyrin level
d. cardiac enzymes
e. liver function tests
3. Potential sources of dietary lead include:
a. solder used to seal food and drink containers
b. imported pottery
c. household dirt and dust
d. folk remedies
e. fresh milk
4. Lead in the body is:
a. bioaccumulated in the bones and teeth
b. associated with erythrocytes in the blood
c. sometimes mobilized in times of stress or malnutrition
d. of no consequence below a level of 10 ng/dL
e. always a potential health risk
5. Children are generally at greater risk than adults from the effects of lead because:
a. children show a greater prevalence of iron deficiency
b. children commonly drink more milk
c. children consume more sweets
d. children ingest more dirt
e. children show a greater sensitivity to lead’s effects
6. Erythrocyte protoporphyrin (EP) or zinc protoporphyrin (ZPP) values may be elevated:
a. when blood lead levels are chronically elevated
b. in hyperbilirubinemia
c. in acroosteolysis
d. in erythropoietic protoporphyria
e. in iron deficiency anemia
7. The following information obtained during a medical evaluation may provide clues to a potential lead 
exposure:
a. occupational history of all home occupants
b. location, age, and physical condition of residence
c. family activities such as home remodeling
d. source of drinking water
e. health of household pets
8. The following are symptoms of mild (rather than severe) lead toxicity:
a. myalgia






CASE STUDIES IN ENVIRONMENTAL MEDICINE: LEAD
If you wish CME credits or CEUs, please indicate your answers to the Posttest questions on page 26 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency forToxic Substances and Disease Registry, Division of Health Education, E33,1600 Clifton Road, Atlanta, 
GA 30333.
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire
Please complete the following evaluation by circling your response.
1. Was the breadth of information in this issue sufficient for your needs?
Yes No Undecided
2. Was the amount of detail appropriate?
Too technical Just right Not technical enough
3. As a result of reading this issue, will you now ask patients more questions regarding possible 
environmental exposures?
Yes No Undecided Not applicable
4. Would you recommend this issue to your colleagues?
Yes No Undecided
5. Will you keep this issue as a reference?
Yes No Undecided 
Comments:_______________________________________________________________________
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To obtain credit, please provide the requested information below.
NAME ____________________________________________
ADDRESS _________________________________________
_____________________________ Z IP _______
Check one:
□  CME - AMA □  CME - AAFP □  CME - ACEP □  CME - AOA 
Medical license no. _____________________________  State ____
□  CEU Social Security no. _______________________






CONTINUING EDUCATION COORDINATOR 
Agency for Toxic Substances and Disease Registry 
Division of Health Education, E33 
1600 Clifton Road 
Atlanta, GA 30333
FOLD HERE SECOND
Please send me the following Case Studies in Environmental Medicine:
a arsenic □  methylene chloride
□ asbestos □  polyaromatic hydrocarbons (PAHs)
□ benzene □  polychlorinated biphenyls (PCBs)
□ cadmium □  radon
□ chromium □  tetrachloroethylene
□ cyanide □  trichloroethylene
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